Faculty
Oncology Division

Milan G. Chheda, MD
Associate Professor
Department of Medicine
Oncology Division
Molecular Oncology
Clinical Interests
- Aggressive treatment of brain tumors
- Maintenance of excellent quality of life
Research Interests
- Cancer stem cells
- Oncolytic viruses
- Functional genomics of brain tumors
Contact
- 314-747-2712 (office)
- 314-362-7086 (fax)
- mchheda@dom.wustl.edu
- Division of Oncology
Mail Stop 8069-0004-07
Washington University
660 South Euclid Avenue
St. Louis, MO 63110 - Center for Advanced Medicine, Suite 7A (clinic)
--
Room 7609 BJC Institute of Health (office) - Milan Chheda lab
Biosketch
Education | |
---|---|
1989-1993 | AB in Physics and Mathematics, Harvard College, Cambridge, MA |
1993-1994 | Wallenberg Scholar, Hebrew University of Jerusalem, Jerusalem, Israel |
1996-2001 | MD, Albert Einstein College of Medicine, New York, NY |
2006 | Certificate in Clinical Effectiveness, Harvard School of Public Health, Boston, MA |
Post-graduate Training | |
2001-2002 | Intern in Internal Medicine, Department of Medicine, Yale-New Haven Hospital, New Haven, CT |
2002-2005 | Resident in Neurology, Department of Neurology, Massachusetts General Hospital and Brigham and Women's Hospital, Boston, MA |
2005-2007 | Fellow in Neuro-oncology, Department of Neurology, Massachusetts General Hospital, Dana-Farber Cancer Institute, and Brigham and Women's Hospital, Boston, MA |
2007-2015 | Postdoctoral Fellow, Laboratory of William C. Hahn, Dana-Farber Cancer Institute, Boston, MA and Broad Institute, Cambridge, MA |
2010-2015 | Postdoctoral Fellow, Laboratory of Ingo L. Mellinghoff, Memorial Sloan-Kettering Cancer Center, New York, NY |
Academic Positions | |
2007-2010 | Clinical Instructor in Neurology, Harvard Medical School, Boston, MA |
2010-2015 | Clinical Instructor in Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY |
2015-2021 | Assistant Professor, Department of Medicine, Division of Oncology and Department of Neurology, Washington University School of Medicine, St. Louis, MO |
2017-present | Co-leader, Neuro-oncology, Mechanisms of Cancer Biology Program (previously Cell-to-Cell Communications in Cancer), Alvin J. Siteman Cancer Center |
2020-present | Director, Neuro-oncology Fellowship Program (United Council of Neurologic Subspecialties), Washington University School of Medicine, St. Louis, MO |
2021-present | Associate Professor, Department of Medicine, Division of Oncology and Department of Neurology, Washington University School of Medicine, St. Louis, MO |
2021-present | Director, Neuro-oncology, Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO |
University & Hospital Appointments & Committees | |
2016-present | Protocol Review Monitoring Committee, Siteman Cancer Center |
Board Certification | |
Board Certification in Neurology, American Board of Psychiatry and Neurology (expired 2018) | |
Board Subspecialty Certification in Neuro-oncology, United Council for Neurologic Subspecialties (expires 2025) | |
Honors & Awards | |
1998 | Howard Hughes Medical Institute - NIH Research Scholar |
1999-2001 | Howard Hughes Medical Institute Continued Support Scholarship |
2001 | MD With Distinction, Albert Einstein College of Medicine |
2001 | Doyle Award in Neuroscience, Albert Einstein College of Medicine |
2005 | Senior Resident Teacher of the Year, Massachusetts General Hospital |
2008-2009 | American Association for Cancer Research-National Brain Tumor Foundation Scholar in Memory of Bonnie Brooks |
2008-2010 | American Brain Tumor Association Basic Science Research Fellow |
2010 | Jerome B. Posner Teaching Award for Neurology Resident Teaching, Memorial Sloan-Kettering Cancer Center |
2018 | Siteman Cancer Center Rock Doc |
2018 | Neuro-oncology Investigator Award, American Academy of Neurology |
2020 | Young Investigator Award, Midwest Tumor Microenvironment Meeting |
Editorial Responsibilities | |
2020-present | Associate Editor, Neuro-oncology Advances |
2020-present | Editorial Board Member, Frontiers in Neurology and Frontiers in Oncology |
National Scientific Panels | |
2015-present | Member, Scientific Review Committee, Medical Student Summer Fellowships, American Brain Tumor Association |
2016-present | Member, Advisory Committee, K12 Training Program in Nervous System Tumors, Massachusetts General Hospital |
2017 | Ad hoc Member, Scientific Review Committee, ZRG1 OBT-G Special Emphasis Panel, Exploratory Grant Award in Basic Cancer Research, NIH |
2017 | Ad hoc Member, Scientific Review Committee, Bankhead-Coley Cancer Research Program and the James and Esther King Biomedical Research Program, Florida Department of Health |
2018-present | Co-chairman, Young Investigator Committee, Society for Neuro-Oncology |
2018 | Ad hoc Member, Scientific Review Committee, CNBT, Clinical Neuroimmunology and Brain Tumors Study Section, NIH |
2019 | Ad hoc Member, Scientific Review Committee, DT, Developmental Therapeutics Study Section, NIH |
2019 | Member, Brain Tumor Immunology Think Tank, Society for Neuro-oncology |
2020 | Ad hoc member, Scientific Review Committee, Health Disparity Research, NCI Loan Repayment Program, NIH |
2020-present | Member, External Advisory Committee, K12 Training Program in Nervous System Tumors, Massachusetts General Hospital |
2020 | Member, Planning Committee, Annual Neuro-Oncology Fellow and Early Clinician/Investigator Career Retreat, Society for Neuro-oncology |
2021 | Ad hoc member, Scientific Review Committee, DT, Developmental Therapeutics Study Section, NIH |
National Meeting Moderator | |
2017 | Cell Signaling, Genetics, Epigenetics; Society for Neuro-Oncology |
2018 | Experimental Therapeutics; Society for Neuro-Oncology |
International Committees | |
2017 | Ad hoc Member, Scientific Review Committee, The Brain Tumour Charity, UK |
Professional Societies | |
2008-present | American Association for Cancer Research |
2011-present | American Academy of Neurology |
2012-present | American Brain Tumor Foundation Alumni Network (Co-chairman, 2013) |
2015-present | Society for Neuro-Oncology |